Global Glycomics Glycobiology Market
Размер рынка в млрд долларов США
CAGR :
% 
USD
24.43 Billion
USD
70.66 Billion
2024
2032
 Прогнозируемый период |
2025 –2032 |
 Размер рынка (базовый год) |
USD 24.43 Billion |
 Размер рынка (прогнозируемый год) |
USD 70.66 Billion |
 CAGR |
% |
| Основные игроки рынка |
|
Global Glycomics/Glycobiology Market Segmentation, By Product (Enzymes, Kits, Reagents and Chemicals, Instruments, Carbohydrates), Application (Drug Discovery and Development, Disease Diagnostics, Other Application), End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories) – Industry Trends and Forecast to 2032.
Glycomics/Glycobiology Market Analysis
One of the most frequent alterations for cell survival is the attachment of glycans. Two types of glycosylation exist. One is N-linked glycosylation: Asparagine glycan attachment and other is O-linked glycosylation: when the glycan is connected to a serine or threonine. Glycomics is a rapidly developing scientific subject that focuses on explaining how glycans operate in biosystems.
Glycomics/Glycobiology Market Size
Global glycomics/glycobiology market size was valued at USD 24.43 billion in 2024 and is projected to reach USD 70.66 billion by 2032, with a CAGR of 14.2% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes |
Glycomics/Glycobiology Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Merck KGaA (Germany), Agilent Technologies Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Shimadzu Corporation (Japan), Takara Bio Inc. (Japan), Waters Corporation (U.S.), Asparia Glycomics S.L. (Spain), Bio-Techne (U.S.), Bruker (U.S.), Danaher (U.S.), RayBiotech, Life Inc. (U.S.), Z Biotech LLC (U.S.), Chemily Glycoscience (U.S.), Dextra Laboratories Ltd. (U.K.), Lectenz Bio (U.S.), and Ludger Ltd. (U.K.) |
|
Market Opportunities |
|
Glycomics/Glycobiology Market Definition
The study of saccharides, which are extensively distributed in nature and are also thought as glycans, and their structure, biology, and function is known as glycomics or glycobiology. Each and every living thing contains glycans. Biotechnology, biomedicine, and basic research are all interested in glycobiology's rapidly developing biological topic.
Glycomics/Glycobiology Market Dynamics
Drivers
- Technological advancements
Technological advancements are thought to promote corporate expansion. Other important aspects that operate as determinants include rising analysis spending by various administration groups and the development of novel drugs by biotechnology and pharmaceutical firms. Additionally, throughout the 2025–2032 forecast period, increasing interest in proteomics examination learnings is anticipated to fuel market growth.
- Rising R&D expenditures
The market is expanding primarily due to rising glycomics research efforts, rising R&D expenditures by pharmaceutical and biotechnology firms, and expanding proteomics sales. On the other hand, developing nations like China and India provide profitable chances for business in this sector.
- Rise in the geriatric population
The rising prevalence of disorders like diabetes and obesity, rising health-care spending, and the fast-growing diagnostic industry are driving the expansion of the global glycomics/glycobiology market.
Opportunities
The market for glycomics and glycobiology is being driven primarily by rising investments in research and development by pharmaceutical and biotechnology businesses and expansion in the proteomics sector. For other businesses in this industry, developing nations provide lucrative opportunities.
Restraints/Challenges
On the other hand, the huge expense of devices will obstruct the market's growth rate.
This glycomics/glycobiology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glycomics/glycobiology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Glycomics/Glycobiology Market Scope
The glycomics/glycobiology market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Enzymes
- Glycosidases and Neuramidases
- Glycosyltransferases and Sialytransferases
- Other Enzymes
- Carbohydrate kinases
- Carbohydrate sulfotransferases
- Protein sulfotransferases
- Sulfatases
- Instruments
- Mass Spectrometry Instruments
- Chromatography Instruments
- Arrays
- Other Instruments
- electrophoresis instruments
- NMR instruments
- HPLC columns
- Kits
- Glycan Releasing Kits
- Glycan Labeling Kits
- Glycan Purification Kits
- Other Kits
- Glycan detection kits
- Glycan enrichment kits
- Glycan sample preparation kits
- Carbohydrates
- Oligosaccharides
- Monosaccharides
- Other Carbohydrates
- Rare sugars
- Glycoproteins
- Glycolipids
- Glycol peptides
- Reagents and Chemicals
Application
- Drug Discovery and Development
- Disease Diagnostics
- Other Applications
- Virology
- Cell biology
- Microbiology
End-user
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
Glycomics/Glycobiology Market Regional Analysis
The glycomics/glycobiology market is analyzed and market size insights and trends are provided by country, product type, application and end-user as referenced above.
The countries covered in the glycomics/glycobiology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the glycomics/glycobiology market due to increased funding for glycomics research, rising R&D spending in pharmaceutical companies for the creation of new medicines, and the close proximity of the necessary personnel.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2025 to 2032 owing to the rising health awareness among the people and rising demand of advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Glycomics/Glycobiology Market Share
The glycomics/glycobiology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to glycomics/glycobiology market.
Glycomics/Glycobiology Market Leaders Operating in the Market Are:
- Merck KGaA (Germany)
- Agilent Technologies Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Shimadzu Corporation (Japan)
- Takara Bio Inc. (Japan)
- Waters Corporation (U.S.)
- Asparia Glycomics S.L. (Spain)
- Bio-Techne (U.S.)
- Bruker (U.S.)
- Danaher (U.S.)
- RayBiotech, Life Inc. (U.S.)
- Z Biotech LLC (U.S.)
- Chemily Glycoscience (U.S.)
- Dextra Laboratories Ltd. (U.K.)
- Lectenz Bio (U.S.)
- Ludger Ltd. (U.K.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
